Systematic (IUPAC) name | |
---|---|
1-ethyl-6-fluoro-4-oxo-7-(piperazin-1-yl)-1,4-dihydro-1,8-naphthyridine-3-carboxylic acid | |
Clinical data | |
AHFS/Drugs.com | monograph |
MedlinePlus | a601013 |
Pregnancy cat. | ? |
Legal status | ? |
Routes | Oral |
Identifiers | |
CAS number | 74011-58-8 |
ATC code | J01MA04 |
PubChem | CID 3229 |
DrugBank | APRD00947 |
ChemSpider | 3116 |
UNII | 325OGW249P |
KEGG | D00310 |
ChEBI | CHEBI:157175 |
ChEMBL | CHEMBL826 |
Chemical data | |
Formula | C15H17FN4O3 |
Mol. mass | 320.319 g/mol |
SMILES | eMolecules & PubChem |
|
|
(verify) |
(what is this?)
Enoxacin (sold under the following trade names Almitil, Bactidan, Bactidron, Comprecin, Enoksetin, Enoxen, Enroxil, Enoxin, Enoxor, Flumark, Penetrex, Gyramid, Vinone) is an oral broad-spectrum fluoroquinolone antibacterial agent used in the treatment of urinary tract infections and gonorrhea. Insomnia is a common adverse effect.[1][2] It is no longer available in the United States.
|